Bristol-Myers Squibb Co. (NYSE:BMY)

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Interest Takes a Big Step Back

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) a close ...
Read Full Story »

Major Pharma Short Sellers Become More Selective

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The Top 20 S&P 500 Companies Buying Back Stock in 2017

Long-term investors have generally been a fan of stock buybacks and dividends. After all, dividends can account for about half of all shareholder returns over time. And buybacks can help ...
Read Full Story »

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

Health care is a sector that has been good to investors so far this year, and some of the top pharmaceutical and biotech companies have posted outstanding results. While there ...
Read Full Story »

Short Sellers Grow More Selective on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Celldex Therapeutics Sinks Following ASCO Results

Celldex Therapeutics Inc. (NASDAQ: CLDX) was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside. ...
Read Full Story »

7 ASCO Stocks Moving on Cancer Study News (Updated)

Note: Share prices have been updated. The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on ...
Read Full Story »

15 Companies Bracing for Big ASCO Reactions

This year marks the 53rd Annual Meeting for the American Society of Clinical Oncology (ASCO), where biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference (June ...
Read Full Story »

Big Pharma Has Big Catalysts Coming for the Rest of 2017

The big pharmaceutical stocks are one area that has done somewhat better this year. One major reason for that is the shrill rhetoric from politicians has quieted as the election ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Any way you look at it, the market has run for a very long time. In fact, it has been more than eight years since the S&P 500 hit an ominous ...
Read Full Story »